Sangamo Therapeutics Inc (SGMO) — Cash Flow-to-Debt Ratio
Sangamo Therapeutics Inc (SGMO) has a Cash Flow-to-Debt Ratio of -0.35x as of September 2025, meaning its operating cash flow of $-28.50 Million could theoretically repay 0% of its total liabilities ($82.40 Million) in one year. Explore Sangamo Therapeutics Inc (SGMO) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sangamo Therapeutics Inc Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Sangamo Therapeutics Inc across 26 annual periods. Also explore SGMO total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Sangamo Therapeutics Inc (1999–2024)
Year-by-year debt coverage analysis for Sangamo Therapeutics Inc. For market capitalisation and broader financial context, see market value of Sangamo Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.85x | $-67.14 Million | $78.86 Million | ▲ +68.8% |
| 2023 | -2.73x | $-224.84 Million | $82.43 Million | ▼ -226.3% |
| 2022 | -0.84x | $-223.63 Million | $267.55 Million | ▼ -24.2% |
| 2021 | -0.67x | $-233.25 Million | $346.58 Million | ▼ -274.8% |
| 2020 | 0.39x | $169.88 Million | $441.18 Million | ▲ +154.6% |
| 2019 | -0.71x | $-144.40 Million | $204.78 Million | ▼ -524.9% |
| 2018 | 0.17x | $37.15 Million | $223.88 Million | ▲ +46.7% |
| 2017 | 0.11x | $11.18 Million | $98.84 Million | ▲ +103.7% |
| 2016 | -3.04x | $-65.88 Million | $21.70 Million | ▼ -123.3% |
| 2015 | -1.36x | $-33.72 Million | $24.80 Million | ▼ -776.5% |
| 2014 | -0.16x | $-5.67 Million | $36.58 Million | ▲ +84.8% |
| 2013 | -1.02x | $-19.48 Million | $19.13 Million | ▼ -122.3% |
| 2012 | -0.46x | $-8.08 Million | $17.64 Million | ▲ +87.3% |
| 2011 | -3.59x | $-25.89 Million | $7.20 Million | ▼ -6.5% |
| 2010 | -3.37x | $-23.93 Million | $7.09 Million | ▼ -761.0% |
| 2009 | -0.39x | $-6.14 Million | $15.66 Million | ▲ +71.9% |
| 2008 | -1.39x | $-17.34 Million | $12.45 Million | ▼ -2.1% |
| 2007 | -1.36x | $-16.07 Million | $11.78 Million | ▲ +33.3% |
| 2006 | -2.05x | $-14.48 Million | $7.08 Million | ▼ -461.7% |
| 2005 | -0.36x | $-4.07 Million | $11.17 Million | ▲ +91.6% |
| 2004 | -4.33x | $-10.16 Million | $2.35 Million | ▲ +8.6% |
| 2003 | -4.74x | $-7.44 Million | $1.57 Million | ▲ +3.0% |
| 2002 | -4.88x | $-9.67 Million | $1.98 Million | ▼ -113.3% |
| 2001 | -2.29x | $-6.11 Million | $2.67 Million | ▼ -89.8% |
| 2000 | -1.21x | $-2.45 Million | $2.04 Million | ▲ +34.7% |
| 1999 | -1.85x | $-2.40 Million | $1.30 Million | — |